California-Based Biotech Rallies Strongly Following $558.4M Divestiture
03 Dezembro 2024 - 4:20PM
AllPennyStocks.com
A California-based biotech company found a
tremendous amount of success on Tuesday following the company
announcing an agreement to divest its Udenyca franchise for
$558.4...
To read the full story on AllPennyStocks.com, click
here.
Coherus BioSciences (NASDAQ:CHRS)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Coherus BioSciences (NASDAQ:CHRS)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
